|
|
Previous Article | Table of Contents | Next Article 
Blood, Vol. 93 No. 8 (April 15), 1999:
pp. 2502-2505
HFE Mutations Analysis in 711 Hemochromatosis Probands: Evidence
for S65C Implication in Mild Form of Hemochromatosis
Catherine Mura,
Odile Raguenes, and
Claude Férec
From the Centre de Biogénétique, ETSBO, CHU, UBO, BP454,
Brest, France.
Hereditary hemochromatosis (HH) is a common autosomal recessive
genetic disorder of iron metabolism. The HFE candidate gene encoding an HLA class I-like protein involved in HH was identified in
1996. Two missense mutations have been described: C282Y, accounting for
80% to 90% of HH chromosomes, and H63D, which is associated with a
milder form of the disease representing 40% to 70% of non-C282Y HH
chromosomes. We report here on the analysis of C282Y, H63D, and the
193A T substitution leading to the S65C missense substitution in a large series of probands and controls. The results confirm that
the C282Y substitution was the main mutation involved in hemochromatosis, accounting for 85% of carrier chromosomes, whereas the H63D substitution represented 39% of the HH chromosomes that did
not carry the C282Y mutation. In addition, our screening showed that
the S65C substitution was significantly enriched in probands with at
least one chromosome without an assigned mutation. This substitution
accounted for 7.8% of HH chromosomes that were neither C282Y nor H63D.
This enrichment of S65C among HH chromosomes suggests that the S65C
substitution is associated with the mild form of hemochromatosis.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. H. Aamodt, L. J. Stovner, K. Thorstensen, S. Lydersen, L. R White, and J. O Aasly
Prevalence of haemochromatosis gene mutations in Parkinson's disease
J. Neurol. Neurosurg. Psychiatry,
March 1, 2007;
78(3):
315 - 317.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. W. Swinkels, M. C.H. Janssen, J. Bergmans, and J. J.M. Marx
Hereditary Hemochromatosis: Genetic Complexity and New Diagnostic Approaches
Clin. Chem.,
June 1, 2006;
52(6):
950 - 968.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-U. Hahn, M. Steiner, S. Bochnig, H. Schmidt, P. Schuff-Werner, and W. Kerner
Evaluation of a Diagnostic Algorithm for Hereditary Hemochromatosis in 3,500 Patients With Diabetes
Diabetes Care,
February 1, 2006;
29(2):
464 - 466.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Brissot and F. de Bels
Current Approaches to the Management of Hemochromatosis
Hematology,
January 1, 2006;
2006(1):
36 - 41.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H. Bernacki, J. C. Beck, K. Muralidharan, F. V. Schaefer, A. E. Shrimpton, K. L. Richie, B. C. Levin, G. Pont-Kingdon, and T. T. Stenzel
Characterization of Publicly Available Lymphoblastoid Cell Lines for Disease-Associated Mutations in 11 Genes
Clin. Chem.,
November 1, 2005;
51(11):
2156 - 2159.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H. Bernacki, J. C. Beck, A. K. Stankovic, L. O. Williams, J. Amos, K. Snow-Bailey, D. H. Farkas, M. J. Friez, F. M. Hantash, K. J. Matteson, et al.
Genetically Characterized Positive Control Cell Lines Derived from Residual Clinical Blood Samples
Clin. Chem.,
November 1, 2005;
51(11):
2013 - 2024.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Yang, T. Yaoi, S. Huang, Q. Yang, S. Hatcher, H. Seet, and J. P. Gregg
Detecting the C282Y and H63D Mutations of the HFE Gene by Holliday Junction-Based Allele-Specific Genotyping Methods
Clin. Chem.,
January 1, 2005;
51(1):
210 - 213.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Hannuksela, M. Leppilampi, K. Peuhkurinen, S. Karkkainen, E. Saastamoinen, T. Helio, M. Kaartinen, M. S. Nieminen, P. Nieminen, and S. Parkkila
Hereditary hemochromatosis gene (HFE) mutations C282Y, H63D and S65C in patients with idiopathic dilated cardiomyopathy
Eur J Heart Fail,
January 1, 2005;
7(1):
103 - 108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Pietrangelo
Hereditary Hemochromatosis -- A New Look at an Old Disease
N. Engl. J. Med.,
June 3, 2004;
350(23):
2383 - 2397.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Alustiza, J. Artetxe, A. Castiella, C. Agirre, J. I. Emparanza, P. Otazua, M. Garcia-Bengoechea, J. Barrio, F. Mujica, and J. A. Recondo
MR Quantification of Hepatic Iron Concentration
Radiology,
February 1, 2004;
230(2):
479 - 484.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Scotet, M.-C. Merour, A.-Y. Mercier, B. Chanu, T. Le Faou, O. Raguenes, G. Le Gac, C. Mura, J.-B. Nousbaum, and C. Ferec
Hereditary Hemochromatosis: Effect of Excessive Alcohol Consumption on Disease Expression in Patients Homozygous for the C282Y Mutation
Am. J. Epidemiol.,
July 15, 2003;
158(2):
129 - 134.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Killeen, J. W. Breneman III, A. R. Carillo, J. Liu, and C. S. Hixson
Linked Linear Amplification for Simultaneous Analysis of the Two Most Common Hemochromatosis Mutations
Clin. Chem.,
July 1, 2003;
49(7):
1050 - 1057.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Drakesmith, E. Sweetland, L. Schimanski, J. Edwards, D. Cowley, M. Ashraf, J. Bastin, and A. R. M. Townsend
The hemochromatosis protein HFE inhibits iron export from macrophages
PNAS,
November 26, 2002;
99(24):
15602 - 15607.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P Holmstrom, J Marmur, G Eggertsen, M Gafvels, and P Stal
Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls
Gut,
November 1, 2002;
51(5):
723 - 730.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D Trinder, C Fox, G Vautier, and J K Olynyk
Molecular pathogenesis of iron overload
Gut,
August 1, 2002;
51(2):
290 - 295.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Toomajian and M. Kreitman
Sequence Variation and Haplotype Structure at the Human HFE Locus
Genetics,
August 1, 2002;
161(4):
1609 - 1623.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Mattman, D. Huntsman, G. Lockitch, S. Langlois, N. Buskard, D. Ralston, Y. Butterfield, P. Rodrigues, S. Jones, G. Porto, et al.
Transferrin receptor 2 (TfR2) and HFE mutational analysis in non-C282Y iron overload: identification of a novel TfR2 mutation
Blood,
July 18, 2002;
100(3):
1075 - 1077.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E Ryan, V Byrnes, B Coughlan, A-M Flanagan, S Barrett, J C O'Keane, and J Crowe
Underdiagnosis of hereditary haemochromatosis: lack of presentation or penetration?
Gut,
July 1, 2002;
51(1):
108 - 112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Pissard, L.-T.-A. Huynh, J. Martin, and M. Goossens
HFE Genotyping by Amplification Refractory Mutation System-Denaturing HPLC
Clin. Chem.,
May 1, 2002;
48(5):
769 - 772.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Girouard, Y. Giguere, R. Delage, and F. Rousseau
Prevalence of HFE gene C282Y and H63D mutations in a French-Canadian population of neonates and in referred patients
Hum. Mol. Genet.,
January 1, 2002;
11(2):
185 - 189.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Bathum, L. Christiansen, H. Nybo, K. A. Ranberg, D. Gaist, B. Jeune, N. E. Petersen, J. Vaupel, and K. Christensen
Association of Mutations in the Hemochromatosis Gene With Shorter Life Expectancy
Arch Intern Med,
November 12, 2001;
161(20):
2441 - 2444.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. N. Roy and N. C. Andrews
Recent advances in disorders of iron metabolism: mutations, mechanisms and modifiers
Hum. Mol. Genet.,
October 1, 2001;
10(20):
2181 - 2186.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L Kelly, P. W Lunt, F. Rodrigues, P J Berry, D. M Flynn, P. J McKiernan, D. A Kelly, G. Mieli-Vergani, and T. M Cox
Classification and genetic features of neonatal haemochromatosis: a study of 27 affected pedigrees and molecular analysis of genes implicated in iron metabolism
J. Med. Genet.,
September 1, 2001;
38(9):
599 - 610.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Mura, G. Le Gac, V. Scotet, O. Raguenes, A.-Y. Mercier, and C. Ferec
Variation of iron loading expression in C282Y homozygous haemochromatosis probands and sib pairs
J. Med. Genet.,
September 1, 2001;
38(9):
632 - 636.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. H. Hanson, G. Imperatore, and W. Burke
HFE Gene and Hereditary Hemochromatosis: A HuGE Review
Am. J. Epidemiol.,
August 1, 2001;
154(3):
193 - 206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Lyon and E. L. Frank
Hereditary Hemochromatosis Since Discovery of the HFE Gene
Clin. Chem.,
July 1, 2001;
47(7):
1147 - 1156.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P Aguilar-Martinez, M Bismuth, M C Picot, C Thelcide, G-P Pageaux, F Blanc, P Blanc, J-F Schved, and D Larrey
Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause?
Gut,
June 1, 2001;
48(6):
836 - 842.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Beutler, V. Felitti, T. Gelbart, and N. Ho
Genetics of Iron Storage and Hemochromatosis
Drug Metab. Dispos.,
April 1, 2001;
29(4):
495 - 499.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. L. Sham, R. F. Raubertas, C. Braggins, J. Cappuccio, M. Gallagher, and P. D. Phatak
Asymptomatic hemochromatosis subjects: genotypic and phenotypic profiles
Blood,
December 1, 2000;
96(12):
3707 - 3711.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Beutler, V. Felitti, T. Gelbart, and N. Ho
The Effect of HFE Genotypes on Measurements of Iron Overload in Patients Attending a Health Appraisal Clinic
Ann Intern Med,
September 5, 2000;
133(5):
329 - 337.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. E. Chen, C. Ooi, S. Y. Ha, B. M.Y. Cheung, D. Todd, R. Liang, T. K. Chan, and V. Chan
Genetic and Clinical Features of Hemoglobin H Disease in Chinese Patients
N. Engl. J. Med.,
August 24, 2000;
343(8):
544 - 550.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H. Elsea and V. Leykam
HFE polymorphism and accurate diagnosis of C282Y hereditary hemochromatosis carriers
Blood,
April 1, 2000;
95(7):
2453 - 2455.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. J. Bulaj, J. D. Phillips, R. S. Ajioka, M. R. Franklin, L. M. Griffen, D. J. Guinee, C. Q. Edwards, and J. P. Kushner
Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda
Blood,
March 1, 2000;
95(5):
1565 - 1571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Brittenham, G. Weiss, P. Brissot, F. Laine, A. Guillygomarc'h, D. Guyader, R. Moirand, and Y. Deugnier
Clinical Consequences of New Insights in the Pathophysiology of Disorders of Iron and Heme Metabolism
Hematology,
January 1, 2000;
2000(1):
39 - 50.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. C. Andrews
Disorders of Iron Metabolism
N. Engl. J. Med.,
December 23, 1999;
341(26):
1986 - 1995.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bollhalder, C. Mura, O. Landt, and F. E. Maly
LightCycler PCR Assay for Simultaneous Detection of the H63D and S65C Mutations in the HFE Hemochromatosis Gene Based on Opposite Melting Temperature Shifts
Clin. Chem.,
December 1, 1999;
45(12):
2275 - 2278.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Christiansen, A. Bygum, K. Thomsen, F. Brandrup, M. Horder, and N. E. Petersen
Denaturing Gradient Gel Electrophoresis Analysis of the Hemochromatosis (HFE) Gene: Impact of HFE Gene Mutations on the Manifestation of Porphyria Cutanea Tarda
Clin. Chem.,
November 1, 1999;
45(11):
2025 - 2026.
[Full Text]
[PDF]
|
 |
|
|
|